Sanofi announced price cuts that cap the cost of insulin at $35 for patients back in March. The reduced cost took effect on New Year's Day.

Eli Lilly announced Wednesday a series of price cuts that would lower the price of the most commonly used forms of its insulin 70% and said it will automatically cap out-of-pocket insulin costs at ...

Eli Lilly & Co.’s announcement that it is slashing prices for its major insulin products could make life easier for some diabetes patients while easing pressure on Big Pharma. It also casts ...

Drugmaker Eli Lilly says it will cut its insulin prices up to 70% and cap out-of-pocket costs for privately insured consumers at $35 a month.

Opinion: Miami attorney Gregg Goldfarb says wielding antitrust, fraud, and nuisance claims can help attorneys score wins in litigation against pharmacy benefit managers.

The top 3 insulin makers recently announced price cuts. Here’s what to know Eli Lilly, Novo Nordisk and Sanofi all announced plans to cap prices on the diabetes treatment after pressure from ...

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for low-income health clinics.

After years of political pressure, insulin prices are finally starting to drop, and some New Yorkers are paying less at pharmacies as a result. Yet not everyone with diabetes is benefiting from ...

There are several ways to deliver insulin, but the price of insulin can vary widely, and overall costs may depend on different factors.

Eli Lilly plans to cut prices on its most commonly prescribed insulin products by 70% and will also cap customers' out-of-pocket costs at $35 a month for those with commercial insurance who use ...